Antifungal drugs susceptibility towards candida albicans in female patients with UTI

https://doi.org/10.53730/ijhs.v6nS3.8132

Authors

  • Tannupriya Department of Medical Laboratory Technology, University Institute of Applied Health Sciences, Chandigarh University, Gharuan, Mohali, Punajb-140413
  • Deepika Kapoor Department of Medical Laboratory Technology, University Institute of Allied Health Sciences, Chandigarh University, Gharuan, Mohali, Punajb-140413
  • Vivek Kumar Garg Department of Medical Laboratory Technology, University Institute of Allied Health Sciences, Chandigarh University, Gharuan, Mohali, Punajb-140413

Keywords:

Candida, Candiduria, UTI, antifungal, susceptibility, amphotericin B, fluconazole

Abstract

Background: In women urinary tract infection is a growing concern clinically. The most common human fungal pathogens are candida species reportedly. The aim of the present study was to identify the Candida species causing UTIs and Antifungal susceptibility test. Methods: The study was conducted on 448 urine samples of female patients in Gurugram, Haryana. Urine sample of in-patients and out patients were collected during the period of 2 months for the diagnosis of candida species. Antifungal susceptibility test was done using disk diffusion method. Result: In the present study 13 Candida isolates were found. All the isolates found to be candida albicans (n=13) and Amphotericin B (100%) found to be the most effective drug against Candida albicans followed by voriconazole (92.3%) and fluconazole (61.53%) is the least sensitive drug against C. albicans. Conclusion: Study concluded that only C. albicans species found prevalent fungal species in female. It is also noticed that fungal UTI were less prevalent than bacteria UTI. amphotericin B was 100% sensitive drug towards all the isolates of C.albicans.

Downloads

Download data is not yet available.

References

Tomczak H, Szalek E, Grzes̈kowiak E. The problems of urinary tract infectionswith Candida spp. aetiology in women. Adv Hyg Exp Med [Internet]. 2014 Aug 29 [cited 2022 Apr 28];68:1036–9. Available from: https://phmd.pl/icid/1118989

Fisher JF, Kavanagh K, Sobel JD, Kauffman CA, Newman CA. Candida Urinary Tract Infection: Pathogenesis. Clin Infect Dis [Internet]. 2011 May 15 [cited 2022 Apr 28];52(suppl_6):S437–51. Available from: https://academic.oup.com/cid/article/52/suppl_6/S437/284654

Sobel JD, Fisher JF, Kauffman CA, Newman CA. Candida urinary tract infections--epidemiology. Clin Infect Dis [Internet]. 2011 May 15 [cited 2022 Apr 28];52 Suppl 6(SUPPL. 6):433–6. Available from: https://pubmed.ncbi.nlm.nih.gov/21498836/

Fazeli A, Kordbacheh P, Nazari A, Ghazvini RD, Mirhendi H, Safara M, et al. Candiduria in Hospitalized Patients and Identification of Isolated Candida Species by Morphological and Molecular Methods in Ilam, Iran. Iran J Public Heal [Internet]. 2019 [cited 2022 Apr 28];48(1):156–61. Available from: http://ijph.tums.ac.ir

Behzadi P, Behzadi E, Ranjbar R. Urinary tract infections and Candida albicans. Cent Eur J Urol [Internet]. 2015 [cited 2022 Apr 28];68(1):96–101. Available from: /pmc/articles/PMC4408390/

Gharanfoli A, Mahmoudi E, Torabizadeh R, Katiraii F, Faraji S. Isolation, characterization, and molecular identification of Candida species from urinary tract infections. Curr Med Mycol. 2019 Mar 1;5(2):33–6.

Pramodhini S, Srirangaraj S, Easow JM. Candiduria—Study of Virulence Factors and Its Antifungal Susceptibility Pattern in Tertiary Care Hospital. J Lab Physicians. 2021 Sep;13(03):231–7.

Hof H. A new, broad-spectrum azole antifungal: Posaconazole - Mechanisms of action and resistance, spectrum of activity. Mycoses. 2006;49(SUPPL. 1):2–6.

Jain M, Dogra V, Bibhabati M, Archana T, Sood LP, Aradhana B. Candiduria in catheterized intensive care unit patients : Emerging microbiological trends. Indian J Pathol Microbiol. 2011;54(3):552–5.

Mahmoudabadi AZ, Rezaei-Matehkolaei A, Ghanavati F. The susceptibility patterns of Candida species isolated from urine samples to posaconazole and caspofungin. Jundishapur J Microbiol. 2015 Mar 1;8(3).

Yismaw G, Asrat D, Woldeamanuel Y, Unakal C. Prevalence of candiduria in diabetic patients attending Gondar University Hospital, Gondar, Ethiopia. Iran J Kidney Dis. 2013;7(2):102–7.

Liu S, Hou Y, Chen X, Gao Y, Li H, Sun S. Combination of fluconazole with non-antifungal agents: A promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery. Int J Antimicrob Agents [Internet]. 2014;0924–8579(14):1–8. Available from: http://dx.doi.org/10.1016/j.ijantimicag.2013.12.009

Moazeni Maryam, Nabili Mojtaba. Identification of Candida Species Isolated from Hospitalized Patients with Candiduria. Med Lab J [Internet]. 2022;16(2):13–20. Available from: https://goums.ac.ir/mljgoums/article-1-1363-en.html%0Ahttps://goums.ac.ir/mljgoums/article-1-1363-en.pdf

Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis. 2000;30(1):14–8.

OZHAK-BAYSAN BIL, OGUNC DIL, COLAK DIL, ONGUT G, DONMEZ L, VURAL T, et al. Distribution and antifungal susceptibility of candida species causing nosocomial candiduria. Med Mycol. 2012;50:529–32.

Ural O, Findik D, Arslan U. Risk factors for nosocomial candiduria. 2006;(May 2014).

Zarei-Mahmoudabadi A, Zarrin M, Ghanatir F, Vazirianzadeh B. Candiduria in hospitalized patients in teaching hospitals of Ahvaz. Iran J Microbiol. 2012;4(4):198–203.

Changizi M, Shojaei Zadeh D, Zinat-Motlagh F, Fattahi M, Mahboubi M. Beliefs of Female Teenagers on Prevention of Urinary Tract Infection: Application of Health Belief Model. J Biol Today’s World [Internet]. 2014 [cited 2022 May 6];3(10):223–6. Available from: http://www.journalbio.com

Nademi A, Shahrokh H, Kordbacheh P, Zaini F, Rezaie S. Identification and antifungal susceptibility pattern of Candida species isolated from patients with nosocomial candiduria. J Mycol Res. 2015;2(2):77–84.

Mehta R, Wyawahare A. Species Identification of Candida Isolates in Various Clinical Samples. Int J Adv Res. 2016;4(8):1340–8.

Almeida AA de, Mesquita CSS, Svidzinski TIE, Oliveira KMP de. Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil. Rev Soc Bras Med Trop. 2013;46(3):335–9.

Seifi Z, Azish M, Salehi Z, Mahmoudabadi AZ, Shamsizadeh A. Candiduria in children and susceptibility patterns of recovered Candida species to antifungal drugs in Ahvaz. J Nephropathol. 2013;2(2):122–8.

Published

31-05-2022

How to Cite

Tannupriya, Kapoor, D., & Garg, V. K. (2022). Antifungal drugs susceptibility towards candida albicans in female patients with UTI. International Journal of Health Sciences, 6(S3), 8983–8990. https://doi.org/10.53730/ijhs.v6nS3.8132

Issue

Section

Peer Review Articles

Most read articles by the same author(s)